A.P. Pharma, Inc. (APP) is a specialty pharmaceutical company focused on the development of pharmaceutical products utilizing its proprietary polymer-based drug delivery systems. The Company's focus is the development and commercialization of bioerodible injectable and implantable systems under the trade name Biochronomer. APP's product candidates are APF112 and APF530. Initial targeted areas of application for its drug delivery technologies include pain management, anti-nausea, anti-inflammatory, anti-infective, oncology and ophthalmology applications, device coatings and DNA delivery. The Company has also entered into fee-paying feasibility studies with several companies to develop a variety of products using its Biochronomer delivery systems. These products are being developed in the areas of vaccines, ophthalmology, device coatings and DNA delivery.